T. Liechtenstein

发表

Interference with PD-L1/PD-1 co-stimulation during antigen presentation enhances the multifunctionality of antigen-specific T cells

C. Heirman, K. Thielemans, K. Breckpot, 2013, Gene Therapy.

[Dendritic cells in cancer immunotherapy].

G. Kochan, D. Escors, I. Blanco-Luquin, 2015, Anales del sistema sanitario de Navarra.

Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer

M. de Ridder, K. Breckpot, D. Escors, 2015, Oncotarget.

A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice

K. Breckpot, J. Fernández-Irigoyen, E. Santamaría, 2014, Oncotarget.

Lentiviral Vectors for Cancer Immunotherapy and Clinical Applications

D. Escors, N. Pérez-Janices, T. Liechtenstein, 2013, Cancers.

Immune modulation by genetic modification of dendritic cells with lentiviral vectors.

C. Goyvaerts, K. Breckpot, C. Bricogne, 2013, Virus research.

Assessing T-cell responses in anticancer immunotherapy

C. Goyvaerts, K. Breckpot, A. Lanna, 2013, Oncoimmunology.

MODULATING CO-STIMULATION DURING ANTIGEN PRESENTATION TO ENHANCE CANCER IMMUNOTHERAPY.

K. Breckpot, A. Lanna, D. Escors, 2012, Immunology, endocrine & metabolic agents in medicinal chemistry.

Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes

C. Davatzikos, R. Lencer, D. Dwyer, 2022, Biological Psychiatry.

Lentiviral Vectors in Immunotherapy

K. Breckpot, C. Bricogne, A. Lanna, 2013 .

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance

K. Breckpot, C. Bricogne, A. Lanna, 2012, Scientifica.

Chapter 13 Lentiviral Vectors in Immunotherapy

K. Breckpot, C. Bricogne, A. Lanna, 2018 .

Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity

C. Heirman, K. Thielemans, K. Breckpot, 2014, Oncotarget.

Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy

M. Ridder, C. Goyvaerts, K. Breckpot, 2014, Oncoimmunology.

Targeted Lentiviral Vectors: Current Applications and Future Potential

C. Goyvaerts, K. Breckpot, C. Bricogne, 2013 .

PD-L1/PD-1 Co-Stimulation, a Brake for T cell Activation and a T cell Differentiation Signal.

K. Breckpot, C. Bricogne, A. Lanna, 2012, Journal of clinical & cellular immunology.

Neurobiologically Based Stratification of Recent-Onset Depression and Psychosis: Identification of Two Distinct Transdiagnostic Phenotypes

C. Davatzikos, R. Lencer, D. Dwyer, 2022, Biological Psychiatry.

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis

M. Berdasco, G. Kochan, D. Escors, 2015, Oncotarget.

Manipulating Immune Regulatory Pathways to Enhance T Cell Stimulation

J. Aerts, K. Breckpot, J. Pen, 2014 .

A core of kinase-regulated interactomes defines the neoplastic MDSC lineage

S. Knapp, A. Chaikuad, J. Fernández-Irigoyen, 2015, Oncotarget.